Previous 10 | Next 10 |
2024-01-29 06:06:17 ET The European Commission has approved Takeda's ( NYSE: TAK ) Hyqvia as maintenance therapy in patients of all ages with a neurological disorder called chronic inflammatory demyelinating polyneuropathy (CIDP).... Read the full article on Seeking Alpha ...
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] becomes the Only Facilitated Subcutaneous Immunoglobulin, Offering Patients an up to Once-Monthly Treatment Option At-Home or In-Office Administration Provides CIDP Patients with a Personalized Treatmen...
2024-01-26 12:47:12 ET Summary Today, we take another look at Halozyme Therapeutics, Inc., which enhances drug delivery through its ENHANZE platform, earning royalties and milestone payouts from major drugmakers. Management has plans in place to more than double royalty revenues b...
2024-01-25 17:09:29 ET More on Cognizant Technology Cognizant: 2024 Is Unlikely To Be A Repeat Of 2023 Cognizant Can Go Up And Down, But I Say 'Hold' Cognizant: I Stay Cautious For Now Read the full article on Seeking Alpha For further details see: ...
Cognizant Helping to Modernize Infrastructure and Application Management as Part of Takeda's Digital Transformation PR Newswire Cognizant will support Takeda's ambition to modernize technology capabilities TEANECK, N.J. , Jan. 25, 2024 /PRNewswire/ -- C...
2024-01-23 14:30:35 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Google “How important is sleep?” and you get three billion results . So, it stands to reason that the booming sleep industry isn’t a fad. If that’s the case, inv...
2024-01-21 13:30:00 ET Pharmaceutical companies would be wise to pay attention to developing new treatments for ADHD as there is a demand for improved drugs in the space. Currently, the medications of choice for the condition are stimulant drugs, such as Takeda's ( NYSE: TAK ) V...
Achieved Global Recognition and Top Employer Certification in 24 Countries from Top Employers Institute Global Recognition Reinforces Commitment to Creating an Exceptional People Experience Takeda ( TSE:4502/NYSE:TAK ) today announced that for the sev...
2024-01-16 12:40:46 ET More on Halozyme Therapeutics Halozyme Q3: Navigating The Ups And Downs Of Its Innovative Pathway Halozyme Therapeutics, Inc. (HALO) Q3 2023 Earnings Call Transcript Halozyme Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation ...
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], the Only up to Once Monthly (every 2, 3 or 4 weeks) Subcutaneous Immunoglobulin (SCIG) Infusion to Treat CIDP, Can Be Administered by a Healthcare Professional or Self-Administered after Appropriate Training ...
News, Short Squeeze, Breakout and More Instantly...
Takeda Pharmaceutical Company Limited American Depositary Shares Company Name:
TAK Stock Symbol:
NYSE Market:
Takeda Pharmaceutical Company Limited American Depositary Shares Website:
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
2024-07-04 20:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting and at the Audit and Supervisory Committee meeting, following the 148th Ordinary Meeting of Shareholders, held in Osaka today. Takeda's Board of Directors has 11 members servi...